Your browser doesn't support javascript.
loading
Maternal hyperthyroidism after intrauterine insemination due to hypertrophic action of human chorionic gonadotropin: a case report.
Clin Exp Obstet Gynecol ; 43(3): 446-7, 2016.
Article de En | MEDLINE | ID: mdl-27328512
ABSTRACT
PURPOSE OF INVESTIGATION To report a rare case of maternal hyperthyroidism after intrauterine insemination due to hypertrophic action of hCG. MATERIALS AND

METHODS:

A 36-year-old woman after successful intrauterine insemination and triplet pregnancy, developed hyperthyroidism with resistance to medical treatment.

RESULTS:

All signs of hyperthyroidism resolved and the results of thyroid function tests returned to normal without any medication after embryo meiosis.

CONCLUSIONS:

De novo maternal hyperthyroidism may develop during pregnancy as a result of pathological stimulation of the thyroid gland from the high levels of hCG hormone that can be seen in multiple pregnancies. The risk of hyperthyroidism is related to the number of fetuses. Reversibility of symptomatology can be seen after fetal reduction of multiple pregnancies.
Sujet(s)
Recherche sur Google
Collection: 01-internacional Base de données: MEDLINE Sujet principal: Complications de la grossesse / Propylthiouracile / Antithyroïdiens / Réduction embryonnaire de grossesse multifoetale / Grossesse triple / Gonadotrophine chorionique / Hyperthyroïdie Limites: Adult / Female / Humans / Pregnancy Langue: En Journal: Clin Exp Obstet Gynecol Année: 2016 Type de document: Article
Recherche sur Google
Collection: 01-internacional Base de données: MEDLINE Sujet principal: Complications de la grossesse / Propylthiouracile / Antithyroïdiens / Réduction embryonnaire de grossesse multifoetale / Grossesse triple / Gonadotrophine chorionique / Hyperthyroïdie Limites: Adult / Female / Humans / Pregnancy Langue: En Journal: Clin Exp Obstet Gynecol Année: 2016 Type de document: Article